I have something similar for Q2
Receipts - £9.8m
Payments - £12.4m
Net - -£2.5m
Revenue per consult - £52
Operating cost per consult - £39
DOC appear confident that they can lift their consulting rates. Even with significant growth in consults, it's the only way to reach the annualized £44M. Given we are almost half way through the year and the guidance has been re-affirmed, you'd expect headway is being made. A reversal of Revenue per consult in the upcoming quarterly will be very welcome.
At the end of the day, if Ben's guidance holds, this company becomes much more valuable that it is now. With every guidance affirmation, some of that value should be unlocked.
Ann: Sale of Aust' Subsidiary GP2U Telehealth/Business Update, page-21
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DOC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 268686 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 750 | 1 |
View Market Depth
| Last trade - 09.18am 05/09/2024 (20 minute delay) ? |
| DOC (ASX) Chart |
Day chart unavailable